Comparing shorter and standard TB treatment for people with X-ray signs
Treatments studied
Part of Infections clinical trials.
This study tests whether a shorter course of TB treatment (4 months) works just as well as the standard longer course (6 months) for people whose chest X-ray suggests TB but whose sputum test does not confirm it. It aims to reduce treatment burden while keeping the cure rate high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 17 years or older
- You weigh at least 25 kg
- You were found through a TB screening program (like a mobile chest X-ray) and had an abnormal chest X-ray that suggests possible TB
- You have given a sputum sample for testing, but the test did NOT confirm that you have active TB
- You have not had TB in the past, and you are not currently taking TB medicine
- You agree to complete the full follow-up period (about a year)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a higher dose of the antibiotic rifampicin can shorten tuberculosis treatment from 6 months to 4 months. If you have drug-sensitive TB, this could mean fewer months of medication and fewer side effects.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
This trial tests whether a shorter treatment using the drug rifampicin is as good as the usual longer treatment for people with less severe tuberculosis (TB). If you join, you'd get a shorter course of pills, which might be more convenient and have fewer side effects.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study tests if a shorter course of tuberculosis (TB) medicine works as well as the current longer treatment for children. If successful, it means fewer days of medicine and fewer side effects for kids.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.